IL1B and acute myeloid leukemia: Of note, in vivo AML development was curbed by knockout of IL-1 receptor in the MLL-AF9 mouse model but was increased in FLT3-ITD-driven leukemic mice (122), suggesting different dependencies on IL-1 signaling.